Author: John Murphy, President, COVID-19 Long-haul Foundation
Abstract
Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as a chronic condition with significant long-term health consequences. This article synthesizes current evidence on increased risks of cardiovascular events—including stroke, myocardial infarction, and sudden death—associated with Long COVID. We examine cohort studies, electronic health record analyses, and actuarial modeling of life expectancy to quantify excess mortality. Additionally, we explore public health and insurance implications, including surveillance strategies, disability burden, and risk stratification. These findings underscore the need for integrated clinical, actuarial, and policy responses to mitigate the long-term impact of Long COVID.
1. Introduction
Long COVID affects an estimated 36% of individuals post-infection. Symptoms persist for months and span multiple systems, including neurological, cardiovascular, and immunological domains. While acute COVID-19 mortality has declined, Long COVID presents a subtler but persistent threat to population health. Recent studies reveal elevated risks of cardiovascular events and premature death, even in previously healthy individualsAmerican Heart Association+1.
2. Cardiovascular Sequelae in Long COVID
2.1 Stroke and Cerebrovascular Events
NIH-supported studies confirm a twofold increase in stroke risk up to three years post-infection. Mechanisms include endothelial dysfunction, microclot formation, and persistent inflammation. JAMA (2024) reported elevated stroke incidence in early COVID-19 cohorts, independent of hospitalization statusJAMA Network.
2.2 Myocardial Infarction and Ischemic Heart Disease
COVID-19 survivors face a significantly higher risk of myocardial infarction (MI). Cleveland Clinic data show a four- to sevenfold increase in MI risk among those with severe COVID. Even mild cases are associated with long-term cardiac remodeling and arrhythmiasAmerican College of Cardiology.
2.3 Sudden Cardiac Death
Sudden death has been reported in Long COVID patients with no prior cardiac history. Autopsy studies reveal microvascular thrombosis and myocarditis. The American College of Cardiology emphasizes the need for cardiac screening in post-COVID populations.
3. Actuarial Modeling of Life Expectancy
3.1 Cohort Mortality Analysis
The Society of Actuaries (SOA) published a 2025 report estimating reduced life expectancy in COVID-affected cohorts. Using data from the Human Mortality Database (1985–2023), researchers found excess mortality at one age predicts elevated risk at subsequent ages.
3.2 Continuous Mortality Investigation (CMI)
The UK’s CMI_2024 model incorporates post-pandemic mortality trends. While life expectancy has rebounded slightly, Long COVID introduces uncertainty in projections.
3.3 Insurance and Pension Modeling
WTW and SSA reports highlight the need to adjust mortality assumptions in pension schemes and life insurance underwriting. Long COVID may increase claims related to disability, critical illness, and premature death.
4. Public Health Implications
4.1 Surveillance and Risk Stratification
CDC’s Long COVID initiative emphasizes the importance of surveillance and early intervention. Electronic health records (EHRs) from RECOVER studies enable predictive modeling of high-risk individualsRECOVER COVID Initiative.
4.2 Disability Burden and Workforce Impact
AMA and Managed Healthcare Executive reports estimate that Long COVID contributes to rising disability claims and reduced workforce productivity. Chronic fatigue, cognitive impairment, and cardiovascular symptoms limit return-to-work capacity.
4.3 Health Equity and Access
Long COVID disproportionately affects individuals with chronic conditions, incomplete vaccination, and limited access to care. Public health strategies must address these disparities through targeted outreach and resource allocation.
5. Insurance and Economic Implications
5.1 Coverage and Reimbursement
AHRQ’s 2025 report outlines insurance coverage patterns for Long COVID patients. Many rely on Medicaid or employer-sponsored plans, which may not fully cover rehabilitation or diagnostics.
5.2 Actuarial Risk Adjustment
Insurers are revising underwriting criteria to account for Long COVID risk. This includes higher premiums for post-COVID applicants and expanded critical illness definitions.
5.3 Policy Recommendations
Recommendations include:
- Standardized diagnostic codes for Long COVID
- Expanded disability coverage
- Incentives for preventive care and early treatment
6. Conclusion
Long COVID presents a sustained threat to cardiovascular health, life expectancy, and public infrastructure. Elevated risks of stroke, MI, and sudden death demand proactive screening and intervention. Actuarial models must incorporate Long COVID data to ensure accurate forecasting. Public health and insurance systems must adapt to support affected individuals and mitigate long-term societal costs.
📎 References
- Children with multiple long-term conditions face nearly threefold higher COVID-19 mortality
- More Than One-Third of Individuals With COVID-19 Experience Long COVID
- Nirmatrelvir-Ritonavir Reduces Long COVID Risk in Older Adults
- Physical Activity, Vaccination May Protect Against Long COVID
- Mortality of Post-COVID-19 Condition: 2025 Update – MDPI
- Long COVID in 2025: Latest Research
- RECOVER Research Update: June 2025
- Long-Term Impacts of Exposure to the COVID-19 Pandemic in a Cohort Perspective | SOA
- AHRQ Report Estimates Insurance Sources for Adults With Long COVID
- Long COVID 2025: Symptoms, diagnosis, post-COVID treatments
- The Public Health Approach to Long COVID | CDC
- COVID-19 in 2025: Addressing disease burden and economic impact
- COVID-19 may increase heart attack and stroke risk for years
- Long-term Risk of Heart Attack, Stroke and Death Doubles with History of COVID-19
- First wave of COVID-19 increased risk of heart attack, stroke up to three years later | NIH
- Early COVID-19 Infections Linked With Higher Heart Attack, Stroke Risk | JAMA
- COVID-19 Increases Long-Term Risk of Ischemic and Non-Ischemic Cardiovascular Disease | ACC
- [CMI Model shows rise in cohort life expectancy](https://